Jennifer E Thorne Selected Research

Retinitis

7/2017	Acute Retinal Necrosis: Presenting Characteristics and Clinical Outcomes in a Cohort of Polymerase Chain Reaction-Positive Patients.
6/2014	Viral retinitis following intraocular or periocular corticosteroid administration: a case series and comprehensive review of the literature.
11/2012	Current status of HIV infection and ocular disease.
6/2012	Incidence of cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
4/2012	Clinical outcomes in patients with cytomegalovirus retinitis treated with ganciclovir implant.
10/2011	Evaluation of the United States public health service guidelines for discontinuation of anticytomegalovirus therapy after immune recovery in patients with cytomegalovirus retinitis.
5/2011	Visual field loss in patients with cytomegalovirus retinitis.
8/2006	Incidence of and risk factors for visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
8/2006	Causes of visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
12/2004	Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: 2. Second eye involvement and retinal detachment.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jennifer E Thorne Research Topics

Disease

46	Uveitis 04/2022 - 08/2005
33	Inflammation (Inflammations) 01/2022 - 08/2005
21	Acquired Immunodeficiency Syndrome (AIDS) 01/2022 - 05/2003
20	Panuveitis 01/2021 - 12/2006
13	Cataract (Cataracts) 01/2022 - 08/2006
13	Scleritis (Episcleritis) 01/2022 - 12/2002
12	Retinitis 07/2017 - 05/2003
11	Macular Edema 11/2021 - 09/2011
10	Bullous Pemphigoid (Pemphigoid) 01/2021 - 01/2004
9	Intermediate Uveitis (Chronic Cyclitis) 01/2021 - 10/2009
9	Cytomegalovirus Retinitis 06/2012 - 05/2003
8	Infections 01/2021 - 12/2008
7	Anterior Uveitis 01/2022 - 11/2009
7	Retinal Detachment (Retinal Detachments) 01/2019 - 12/2004
6	Posterior Uveitis 04/2022 - 03/2010
6	Neoplasms (Cancer) 01/2022 - 12/2008
5	Glaucoma 01/2022 - 08/2013
5	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 01/2022 - 05/2007
5	Hypertension (High Blood Pressure) 01/2019 - 10/2015
5	Eye Diseases (Eye Disease) 11/2012 - 08/2005
4	Band-Shaped Corneal Dystrophy 01/2022 - 09/2008
4	Birdshot Chorioretinopathy 01/2022 - 07/2005
3	Hepatitis 01/2021 - 10/2003
3	Vitreous Hemorrhage 01/2019 - 05/2009
2	Granuloma 05/2022 - 12/2009
2	Edema (Dropsy) 01/2022 - 12/2016
2	Necrosis 01/2022 - 07/2009
2	Atrophy 04/2021 - 12/2016
2	COVID-19 01/2021 - 01/2021
2	Macular Degeneration (Age-Related Maculopathy) 01/2019 - 09/2007
2	Retinal Vein Occlusion 01/2017 - 04/2015
2	Epiretinal Membrane (Epiretinal Membranes) 01/2017 - 05/2007
2	Overweight 10/2016 - 01/2016
2	Obesity 10/2016 - 01/2016
2	Opportunistic Infections (Opportunistic Infection) 04/2015 - 02/2013
2	Optic Nerve Diseases (Optic Neuropathy) 08/2013 - 04/2007
2	Choroidal Neovascularization 09/2007 - 12/2006
2	Conjunctivitis 09/2006 - 08/2003
1	Ocular Hypertension (Glaucoma, Suspect) 01/2022
1	T-Cell Lymphoma (Lymphoma, T Cell) 01/2022
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022
1	Hepatocellular Carcinoma (Hepatoma) 01/2021
1	Substance-Related Disorders (Drug Abuse) 12/2019
1	Myocardial Infarction 01/2019
1	Chronic Renal Insufficiency 01/2019
1	Type 2 Diabetes Mellitus (MODY) 01/2019

Drug/Important Bio-Agent (IBA)

49	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2022 - 12/2002
19	Prednisone (Sone)FDA LinkGeneric 04/2022 - 06/2003
14	SteroidsIBA 12/2020 - 10/2011
11	Retinaldehyde (Retinal)IBA 04/2021 - 12/2002
10	Fluocinolone Acetonide (Capex)FDA LinkGeneric 11/2017 - 10/2011
7	Immunosuppressive Agents (Immunosuppressants)IBA 04/2016 - 10/2008
6	Pharmaceutical PreparationsIBA 01/2022 - 07/2009
6	RNA (Ribonucleic Acid)IBA 01/2022 - 04/2015
6	Mycophenolic Acid (Cellcept)FDA LinkGeneric 03/2010 - 12/2002
5	Adalimumab (Humira)FDA Link 11/2021 - 09/2016
5	Matrix Metalloproteinases (MMPs)IBA 01/2021 - 01/2004
5	AntimetabolitesIBA 01/2016 - 10/2008
4	Dexamethasone (Maxidex)FDA LinkGeneric 04/2022 - 01/2015
4	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2021 - 07/2004
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2010 - 12/2008
4	Methotrexate (Mexate)FDA LinkGeneric 11/2009 - 10/2008
4	Azathioprine (Imuran)FDA LinkGeneric 10/2009 - 10/2008
3	Triamcinolone (Aristocort)FDA Link 01/2019 - 09/2007
3	Triamcinolone Acetonide (Azmacort)FDA LinkGeneric 01/2019 - 09/2011
3	Alkylating AgentsIBA 12/2013 - 12/2008
3	Fluorescein (Funduscein)FDA LinkGeneric 09/2013 - 09/2007
3	Cyclosporine (Ciclosporin)FDA LinkGeneric 03/2010 - 08/2003
2	CholesterolIBA 01/2019 - 10/2015
2	GlucocorticoidsIBA 09/2016 - 11/2007
2	Biological ProductsIBA 01/2016 - 12/2013
2	HLA-B27 Antigen (HLA B27 Antigen)IBA 01/2014 - 02/2010
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2013 - 12/2008
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 12/2009 - 03/2004
2	AutoantibodiesIBA 07/2008 - 01/2004
1	difluprednate FDA Link 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2021
1	Surface Antigens (Surface Antigen)IBA 01/2021
1	Hepatitis B e AntigensIBA 01/2021
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019

Therapy/Procedure

44	Therapeutics 01/2022 - 06/2003
14	Highly Active Antiretroviral Therapy (HAART) 01/2021 - 05/2003
7	Art Therapy 01/2019 - 01/2013
5	Injections 01/2021 - 09/2011
5	Vitrectomy 01/2017 - 11/2012
5	Drug Therapy (Chemotherapy) 12/2008 - 06/2003
3	Aftercare (After-Treatment) 04/2012 - 09/2008
2	Trabeculectomy (Trabeculoplasty) 01/2022 - 01/2022
2	Lasers (Laser) 01/2022 - 01/2017
2	Immunomodulation 01/2021 - 08/2016
2	Biological Therapy 04/2017 - 07/2008
2	Tattooing 11/2015 - 09/2014
2	Intraocular Injections 11/2014 - 08/2013
1	Penetrating Keratoplasty 05/2022
1	Transplantation 01/2022
1	Immunotherapy 01/2019
1	Intravitreal Injections 01/2019